Page last updated: 2024-10-22

alendronate and Cardiovascular Stroke

alendronate has been researched along with Cardiovascular Stroke in 4 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Research Excerpts

ExcerptRelevanceReference
"A 10% increased risk of acute myocardial infarction was found in users of other bisphosphonates as compared to alendronate users within CPRD."5.22Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. ( Abrahamsen, B; Arden, N; Calderon-Larranaga, S; Cooper, C; Hawley, S; Javaid, MK; Judge, A; Khalid, S; Prieto-Alhambra, D; Sami, A; Van Staa, TP, 2022)
" However, an inverse dose-response relationship was seen, with an increased risk in those with low adherence (≤0."1.38Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones? ( Vestergaard, P, 2012)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Khalid, S1
Calderon-Larranaga, S1
Sami, A1
Hawley, S1
Judge, A1
Arden, N1
Van Staa, TP1
Cooper, C1
Abrahamsen, B2
Javaid, MK1
Prieto-Alhambra, D1
Yang, Y2
Rong, X1
Lv, X1
Jiang, W1
Lai, D1
Xu, S1
Fu, G1
Eiken, P1
Brixen, K1
Vestergaard, P1

Reviews

1 review available for alendronate and Cardiovascular Stroke

ArticleYear
Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2022, Volume: 33, Issue:7

    Topics: Alendronate; Bone Density Conservation Agents; Cohort Studies; Databases, Factual; Diabetes Mellitus

2022

Other Studies

3 other studies available for alendronate and Cardiovascular Stroke

ArticleYear
Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway.
    Cardiovascular therapeutics, 2017, Volume: 35, Issue:5

    Topics: Alendronate; Animals; Calcium Signaling; Calcium-Binding Proteins; Cardiomyopathy, Dilated; Cell Lin

2017
Atrial fibrillation in fracture patients treated with oral bisphosphonates.
    Journal of internal medicine, 2009, Volume: 265, Issue:5

    Topics: Aged; Aged, 80 and over; Alendronate; Atrial Fibrillation; Bone Density Conservation Agents; Case-Co

2009
Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones?
    Calcified tissue international, 2012, Volume: 90, Issue:1

    Topics: Aged; Alendronate; Atherosclerosis; Bone Density Conservation Agents; Calcium; Cohort Studies; Dipho

2012